Clinical Trials Directory

Trials / Completed

CompletedNCT02079285

Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation

Prospective Evaluation of the Yield and Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy in the Absence of Rapid Onsite Evaluation

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
Kangbuk Samsung Hospital · Academic / Other
Sex
All
Age
19 Years – 85 Years
Healthy volunteers
Not accepted

Summary

\<Background/aims\> Rapid onsite evaluation (ROSE) of endoscopic ultrasound-guided fine needle aspiration and biopsy (EUS-FNAB) specimens by attending cytopathologists has been demonstrated to improve diagnostic yields of EUS-FNAB. The practice of ROSE, however, varies across EUS programs in Unites States, Europe and other areas of world. The investigators have a plan to perform prospective evaluation of the yield of EUS-FNAB in the absence of ROSE, in which the adequacy of specimens will be assessed by a single endosonographer. \<Methods\> All EUS-FNAB procedures will be performed by an experienced endosonographer and the adequacy of specimens obtained during EUS-FNAB will be also assessed by a same endosonographer. A specimen will be considered adequate if there is an adequate number of representative cells from the lesion. Samples considered to be adequate will be then interpreted as malignancy, highly atypical suggestive of malignancy, atypical favor reactive change, or negative for malignancy. Performance characteristics of EUS-FNAB including sensitivity, specificity, and accuracy will be determined by comparing EUS-FNAB results with the final diagnoses of the lesions, based upon the surgical pathology or clinical follow-up of more than 6 months with repeat imagings.

Conditions

Interventions

TypeNameDescription
PROCEDUREEUS-FNA

Timeline

Start date
2014-04-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-03-05
Last updated
2016-02-24

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02079285. Inclusion in this directory is not an endorsement.